Point-of-Care Assays for Infliximab Therapeutic Drug Monitoring in Patients with IBD: Is Quicker Better?

被引：0
|
作者：
Levitte, Steven [1 ]
机构：
[1] Stanford Univ, Div Pediat Gastroenterol Hepatol & Nutr, 750 Welch Rd Ste 116, Palo Alto, CA 94304 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期
关键词：
D O I：
10.1007/s10620-023-08140-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [1] Point-of-Care Assays for Infliximab Therapeutic Drug Monitoring in Patients with IBD: Is Quicker Better?
    Steven Levitte
    Digestive Diseases and Sciences, 2024, 69 : 5 - 6
  • [2] Point-of-care testing in therapeutic drug monitoring of infliximab
    Sahinovic, I.
    Fric, V. Orsic
    Konjik, V.
    Pavela, J.
    Borzan, V.
    Seric, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I490 - I491
  • [3] Point-of-care testing in therapeutic drug monitoring of infliximab
    Sahinovic, I.
    Fric, V. Orsic
    Konjik, V.
    Pavela, J.
    Borzan, V.
    Seric, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I490 - I491
  • [4] Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with Adalimumab
    Cherry, Mohamad
    Dutzer, Dominique
    Nasser, Yara
    Berger, Anne-Emmanuelle
    Roblin, Xavier
    Paul, Stephane
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 10
  • [5] Clinical utility of a point-of-care test for therapeutic drug monitoring of infliximab
    Khoo, E.
    Simms, L.
    Lord, A.
    Hanigan, K.
    Croft, A.
    Radford-Smith, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 122 - 122
  • [6] Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD
    Yara Nasser
    Rémi Labetoulle
    Ines Harzallah
    Anne-Emmanuelle Berger
    Xavier Roblin
    Stephane Paul
    Digestive Diseases and Sciences, 2018, 63 : 2714 - 2721
  • [7] Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD
    Nasser, Yara
    Labetoulle, Remi
    Harzallah, Ines
    Berger, Anne-Emmanuelle
    Roblin, Xavier
    Paul, Stephane
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (10) : 2714 - 2721
  • [8] Therapeutic Drug Monitoring (TDM) Point-of-Care Assays for LH, FSH, and hCG
    Hwang, Larn
    Hsiao, Chao
    Vuong Trieu
    FERTILITY AND STERILITY, 2012, 97 (03)
  • [9] THERAPEUTIC DRUG MONITORING OF BIOSIMILARS OF INFLIXIMAB CAN BE ASSESSED BY THE NEW INFLIXIMAB POINT-OF-CARE QUANTITATIVE TEST
    Afonso, Joana
    Sousa, Helena T.
    Rosa, Isadora
    Carvalho, Jooa
    Dias, Camila
    Magro, Fernando
    GASTROENTEROLOGY, 2017, 152 (05) : S608 - S608
  • [10] Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays
    Afonso, J.
    Lopes, S.
    Goncalves, R.
    Caldeira, P.
    Lago, P.
    Tavares de Sousa, H.
    Ramos, J.
    Goncalves, A. R.
    Ministro, P.
    Rosa, I.
    Vieira, A. I.
    Dias, C. C.
    Magro, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (07) : 684 - 692
12345